Authors

"Saratov Journal of Medical Scientific Research"  publishes peer-reviewed articles on all aspects of clinical medicine and public health, including original clinical studies, experimental investigations with clear clinical relevance, state-of-the-art papers, and viewpoints. In general, case reports will not be considered for publication.
Please read and follow these instructions carefully; doing so will ensure that the publication of your manuscript is as rapid and efficient as possible. The Publisher reserves the right to return manuscripts that are not prepared in accordance with these instructions.
We recommend that all manuscripts be submitted online at E-mail: ssmj@list.ru.

Authors should submit Word or rich-text files by the journal’s preferred method.
 
Preparation of the manuscript
General: Papers must be written in English or Russian.
All text, references, figure legends, and tables should be in one electronic document. You must upload your figures separately.
Full papers of an experimental or observational nature must be divided into sections headed Introduction, Methods (including ethical and statistical information), Results, Discussion, Conclusion and Conflict of interest, although reviews may require a different format.
Legends for all figures should be included in the file with the text and should not appear on the figures. For Original Articles, there is normally a limit of 5 figures and tables (total) per manuscript.
Except for units of measurement, abbreviations are strongly discouraged. Except for units of measurement, the first time an abbreviation appears, it should be preceded by the words for which it stands.
Drug Names. Generic names should be used. When proprietary brands are used in research, include the brand name and the name of the manufacturer in parentheses after the first mention of the generic name in the Methods section.
 
Abstract
Provide an abstract of not more than 1500 symbols. It should consist of four paragraphs, labeled Background, Methods, Results, and Conclusions. They should briefly describe, respectively, the problem being addressed in the study, how the study was performed, the salient results, and what the authors conclude from the results.
 
Statistical Methods
The basis for these guidelines is described in Bailar JC III, Mosteller F. Guidelines for statistical reporting in articles for medical journals: amplifications and explanations. Ann Intern Med 1988;108:266-73.

• Exact methods should be used as extensively as possible in the analysis of categorical data. For analysis of measurements, nonparametric methods should be used to compare groups when the distribution of the dependent variable is not normal.
• Results should be presented with only as much precision as is of scientific value. For example, measures of association, such as odds ratios, should ordinarily be reported to two significant digits.
• Measures of uncertainty, such as confidence intervals, should be used consistently, including in figures that present aggregated results.
• Except when one-sided tests are required by study design, such as in noninferiority trials, all reported P values should be two-sided. In general, P values larger than 0.01 should be reported to two decimal places, those between 0.01 and 0.001 to three decimal places; P values smaller than 0.001 should be reported as P<0.001. Notable exceptions to this policy include P values arising in the application of stopping rules to the analysis of clinical trials and genetic-screening studies.
• In manuscripts that report on randomized clinical trials, authors may provide a flow diagram in CONSORT format and all of the information required by the CONSORT checklist. When restrictions on length prevent the inclusion of some of this information in the manuscript, it may be provided in a separate document submitted with the manuscript.

 
Figure
Figures should be supplied in an electronic format at a suitable size for printing with the following resolutions: 600 dots per inch (dpi) for line drawings and combinations; 300 dpi for greyscale and colour. Acceptable formats for pictures, photos, and figures are PDF, DOC, PPT, JPG, GIF, TIF.
If photographs of patients are used, either they should not be identifiable or the photographs should be accompanied by written permission to use them.
 
References
References must be double-spaced and numbered consecutively as they are cited. References first cited in a table or figure legend should be numbered so that they will be in sequence with references cited in the text at the point where the table or figure is first mentioned. List all authors when there are four or fewer; when there are five or more, list the first three, followed by “et al.” The following are sample references:
1. Takagi, A. The effect of Helicobacter pylori on cell proliferation and apoptosis in gastric epithelial cell lines/ A. Takagi, S. Watanabe, M. Igarashi et al. // Aliment. Pharmacol. Ther. — 2000. — Vol.14, suppl. 1. — P.188–192.
2. Blalock, J.E. (ed). Neuroimmunoendocrinology. Chemical immunology. — Basel: Karger, 1997. — 632 p.
3. U.S. positions on selected issues at the third negotiating session of the Framework Convention on Tobacco Control. Washington, D.C.: Committee on Government Reform, 2002. (Accessed March 4, 2002, at http://www.house.gov/reform/min/inves_tobacco/index_accord.htm.)
Numbered references to personal communications, unpublished data, or manuscripts either “in preparation” or “submitted for publication” are unacceptable. If essential, such material can be incorporated at the appropriate place in the text.
 
CONFLICT OF INTEREST
Authors of research articles should disclose at the time of revision any financial arrangement they may have with a company whose product is pertinent to the submitted manuscript or with a company making a competing product. Such information will be held in confidence while the paper is under review and will not influence the editorial decision, but if the article is accepted for publication, a disclosure statement will appear with the article.
Because the essence of reviews and editorials is selection and interpretation of the literature, the Journal expects that authors of such articles will not have any significant financial interest in a company (or its competitor) that makes a product discussed in the article.
 
Proofs
All manuscripts will undergo some editorial modification, so it is important to check proofs carefully. PDF page proofs will be sent via e-mail to the corresponding author for checking. To avoid delays in publication, proofs should be checked and returned within 48 hours. Corrections should be returned by annotated PDF, e-mail or fax. Extensive changes to the text may be charged to the author.
 
Post-production corrections
Corrections are made if the publication record is seriously affected by the academic accuracy of published information. Where these amendments concern peer-reviewed material, the correction will be published as a formal notice (erratum) in a subsequent issue.
Authors' corrections to Supplementary Data are made only in exceptional circumstances (for example major errors that compromise the conclusion of the study). Because the Supplementary Data is part of the original paper and hence the published record, the information cannot be updated if new data have become available or interpretations have changed.
 
The manuscripts are considered for review only under the conditions that they are not under consideration elsewhere and that the data presented have not appeared on the internet or have not been previously published (including symposia, proceedings, transactions, books, articles published by invitation, and preliminary publications of any kind except abstracts not exceeding 400 words). On acceptance, written transfer of copyright, signed by all authors, will be required.
 
PERMISSIONS
No part of materials published in "Saratov Journal of Medical Scientific Research" may be reproduced without written permission of the publisher.
 
RELATIONSHIP WITH INDUSTRY POLICY
The Editors require authors to disclose any relationship with industry and financial associations that might pose a conflict of interest in connection with the submitted article in both the cover letter and on the title page. All sources of funding for the work should be acknowledged in a footnote on the title page, as should all institutional affiliations of the authors (including corporate appointments). Other kinds of associations, such as consultancies, stock ownership, or other equity interests or patent-licensing arrangements, should be disclosed to the Editors in the cover letter at the time of submission. If no relationship with industry exists, please state this in the cover letter and on the title page. Relationship with industry guidelines apply to authors of all the following: Original Research Papers, State-of-the-Art Papers, Expedited Reviews, Editorials and Viewpoints, Editorial Comments, and Letters to the Editor.
 
ETHICS
Studies should be in compliance with human studies committees and animal welfare regulations of the authors' institutions. Human studies must be performed with the subjects' written informed consent. Authors must provide the details of this procedure and indicate that the institutional committee on human research has approved the study protocol. If radiation is used in a research procedure, the radiation exposure must be specified in the Methods.
Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in your paper. Patients have a right to privacy. Therefore, identifying information, including patientsТ images, names, initials, or hospital numbers, should not be included in videos, recordings, written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and you have obtained written informed consent for publication in print and electronic form from the patient (or parent, guardian, or next of kin where applicable). If such consent is made subject to any conditions, the editorial office must be made aware of all such conditions. Written consents must be provided to the editorial office on request. Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. If such consent has not been obtained, personal details of patients included in any part of the paper and in any supplementary materials (including all illustrations) must be removed before submission.
 
Offprints
Corresponding authors may purchase offprints by mail. On-line version of all articles is free.